Tumour cell resistance to non-MHC-restricted lymphocytes: molecular mechanisms and clinical implications

Cancer Immunol Immunother. 1998 May;46(3):121-7. doi: 10.1007/s002620050470.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Cytokines / therapeutic use
  • Humans
  • Immunity, Cellular / immunology
  • Interleukin-2 / therapeutic use
  • Killer Cells, Lymphokine-Activated / immunology
  • Killer Cells, Natural / immunology
  • Lymphocytes / immunology*
  • Major Histocompatibility Complex / immunology*
  • Mice
  • Neoplasms / immunology*
  • Neoplasms / therapy

Substances

  • Cytokines
  • Interleukin-2